These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 31559249)

  • 1. Alopecia in Autoimmune Blistering Diseases: A Systematic Review of Pathogenesis and Clinical Features of Disease.
    Xie D; Bilgic-Temel A; Abu Alrub N; Murrell DF
    Skin Appendage Disord; 2019 Aug; 5(5):263-275. PubMed ID: 31559249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical manifestations of alopecia in autoimmune blistering diseases: A cross-sectional study.
    Xie D; Bilgic A; Abu Alrub N; Dicle Ö; Murrell DF
    JAAD Int; 2023 Mar; 10():6-13. PubMed ID: 36387063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis and clinical features of alopecia in epidermolysis bullosa: A systematic review.
    Xie D; Bilgic-Temel A; Abu Alrub N; Murrell DF
    Pediatr Dermatol; 2019 Jul; 36(4):430-436. PubMed ID: 31177584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blistering diseases in the mature patient.
    Lakoš Jukić I; Jerković Gulin S; Marinović B
    Clin Dermatol; 2018; 36(2):231-238. PubMed ID: 29566927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of Autoimmune Blistering Diseases.
    Witte M; Zillikens D; Schmidt E
    Front Med (Lausanne); 2018; 5():296. PubMed ID: 30450358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of scoring systems for ocular involvement in chronic cutaneous bullous diseases.
    Lee BWH; Tan JCK; Radjenovic M; Coroneo MT; Murrell DF
    Orphanet J Rare Dis; 2018 May; 13(1):83. PubMed ID: 29789014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.
    Amber KT; Murrell DF; Schmidt E; Joly P; Borradori L
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):26-51. PubMed ID: 28779299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement Activation in Autoimmune Bullous Dermatoses: A Comprehensive Review.
    Edwards G; Diercks GFH; Seelen MAJ; Horvath B; van Doorn MBA; Damman J
    Front Immunol; 2019; 10():1477. PubMed ID: 31293600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal Autoimmune Blistering Disease: A Systematic Review.
    Zhao CY; Chiang YZ; Murrell DF
    Pediatr Dermatol; 2016 Jul; 33(4):367-74. PubMed ID: 27086740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Animal models to investigate pathomechanisms and evaluate novel treatments for autoimmune bullous dermatoses.
    Iwata H; Bieber K; Hirose M; Ludwig RJ
    Curr Pharm Des; 2015; 21(18):2422-39. PubMed ID: 25777758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune blistering dermatoses as systemic diseases.
    Vassileva S; Drenovska K; Manuelyan K
    Clin Dermatol; 2014; 32(3):364-75. PubMed ID: 24767184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of autoimmune blistering diseases: the Pemphigoid diseases.
    Daniel BS; Murrell DF
    J Eur Acad Dermatol Venereol; 2019 Sep; 33(9):1685-1694. PubMed ID: 31087464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune blistering diseases in females: a review.
    Zhao CY; Murrell DF
    Int J Womens Dermatol; 2015 Feb; 1(1):4-12. PubMed ID: 28491949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunofluorescence testing in the diagnosis of autoimmune blistering diseases: overview of 10-year experience.
    Arbache ST; Nogueira TG; Delgado L; Miyamoto D; Aoki V
    An Bras Dermatol; 2014; 89(6):885-9. PubMed ID: 25387492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective studies on the routine use of a novel multivariant enzyme-linked immunosorbent assay for the diagnosis of autoimmune bullous diseases.
    van Beek N; Dähnrich C; Johannsen N; Lemcke S; Goletz S; Hübner F; Di Zenzo G; Dmochowski M; Drenovska K; Geller S; Horn M; Kowalewski C; Medenica L; Murrell DF; Patsatsi A; Uzun S; Vassileva S; Zillikens D; Schlumberger W; Schmidt E
    J Am Acad Dermatol; 2017 May; 76(5):889-894.e5. PubMed ID: 28038887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research Techniques Made Simple: Mouse Models of Autoimmune Blistering Diseases.
    Pollmann R; Eming R
    J Invest Dermatol; 2017 Jan; 137(1):e1-e6. PubMed ID: 28010761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trichoscopy - a useful tool in the preliminary differential diagnosis of autoimmune bullous diseases.
    Sar-Pomian M; Rudnicka L; Olszewska M
    Int J Dermatol; 2017 Oct; 56(10):996-1002. PubMed ID: 28856676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subepithelial autoimmune bullous dermatoses disease activity assessment and therapy.
    Montagnon CM; Lehman JS; Murrell DF; Camilleri MJ; Tolkachjov SN
    J Am Acad Dermatol; 2021 Jul; 85(1):18-27. PubMed ID: 33684494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoporosis and bone health in autoimmune blistering skin disease-an evidenced based review.
    Kang M; Bilgic A; Radjenovic M; Murrell DF
    J Eur Acad Dermatol Venereol; 2020 Dec; 34(12):2745-2756. PubMed ID: 32124493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal adhesion molecules and basement membrane components as target structures of autoimmunity.
    Moll R; Moll I
    Virchows Arch; 1998 Jun; 432(6):487-504. PubMed ID: 9672190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.